Continuous Glucose Monitoring in Obese Pregnant Women with Myo-inositol

This study is exploring the use of a compound called myo-inositol in pregnant individuals who are obese. Myo-inositol is similar to insulin and can be found naturally in the body and in our diet. It helps the body use insulin more effectively, which is particularly useful for managing blood sugar levels. This study is important because it aims to see if myo-inositol can help improve insulin sensitivity and blood sugar control in pregnant individuals, potentially preventing gestational diabetes, a condition that can complicate pregnancies and affect both mother and baby. Participants in this study are randomly assigned to receive either myo-inositol or a placebo, which is a substance with no active ingredients, to compare the effects. This approach is called a double-blind randomized control trial, meaning neither the participants nor the researchers know who is receiving the actual supplement or the placebo. The study uses continuous glucose monitoring to track blood sugar levels over time, helping to assess how well myo-inositol works in managing these levels. The trial is designed to ensure safety and accuracy while gathering data on the potential benefits of myo-inositol as a preventative measure for gestational diabetes.